Pharma Journalist -

Humanetics Corporation (Humanetics) announced that it has entered into a definitive agreement with DSM Nutritional Products Ltd of Kaiseraugst Switzerland to acquire all of DSM’s assets…
Read More...

Five Prime Therapeutics, Inc. announced a global license agreement with Seattle Genetics, Inc. to develop and commercialize novel antibody-drug conjugate (ADC) therapies using…
Read More...

NeoTX Therapeutics, a clinical-stage biotechnology company leveraging its proprietary Selective T cell Redirection (STR) platform to develop targeted anticancer immunotherapies, has…
Read More...

Nimble Therapeutics, Inc. announced a multi-year collaboration with Genentech, a member of the Roche Group, to accelerate discovery and development of novel peptide-based medicines for…
Read More...

St. Louis startup Pluton Biosciences, LLC is pleased to announce that it has acquired Microbe Inotech Laboratories (MiL), Inc., a full-service microbiological lab also headquartered in…
Read More...

Cellectis, a biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), and Servier, an international pharmaceutical company,…
Read More...

Biotage AB (Biotage) announced the launch of a Good Laboratory Practices (GLP) software upgrade for Biotage Extrahera, their flagship automated sample preparation instrument for…
Read More...

Aphena Pharma Solutions Inc. has announced the expansion of its bottling capacity with the purchase of a new, state-of-the-art, high-speed, solid-dose bottling line with an integrated…
Read More...

m8 Pharmaceuticals and Vectans Pharma, announced they have signed an exclusive licensing agreement whereby m8 will have the rights to register and commercialize Loramyc (miconazole) for…
Read More...

Sanofi Pasteur, the vaccines global business unit of Sanofi, will leverage previous development work for a SARS vaccine which may unlock a fast path forward for developing a COVID-19…
Read More...